The Association between Early-Onset Pancreatic Ductal Adenocarcinoma and Patients Survival: A Systematic Review and Meta-Analysis
- PMID: 39355802
- PMCID: PMC11443187
- DOI: 10.12688/f1000research.153743.1
The Association between Early-Onset Pancreatic Ductal Adenocarcinoma and Patients Survival: A Systematic Review and Meta-Analysis
Abstract
Background: In recent years, the incidence of early-onset pancreatic cancer (EOPC) has increased. Several studies comparing the survival of patients with EOPC to those with average-onset pancreatic cancer (AOPC) have reported mixed results. We aimed, therefore, to perform a meta-analysis summarizing the current evidence.
Methods: We searched the MEDLINE and EMBASE databases for relevant articles published through March 2024. Articles comparing the survival of patients with EOPC - defined as pancreatic ductal adenocarcinoma (PDAC) diagnosed at ≤ 50 years of age - and AOPC were included in the present meta-analysis. The primary outcome was the pooled adjusted hazard ratio (aHR), and the risk of bias analysis was performed using the Quality in Prognostic Factor Studies tool. The meta-analysis was performed using a random-effects model.
Results: A total of 17 studies were eligible for the primary analysis, the results of which indicated that patients with EOPC had a longer overall survival than those with AOPC (aHR = 0.80; 95% confidence interval [CI], 0.74-0.86; P < 0.001). The rate of distant metastasis was higher in EOPC than AOPC; however, patients with EOPC also received more treatments than those with AOPC.
Conclusions: Patients with EOPC had a better prognosis than those with AOPC. Clinicians must ensure that patients with PDAC receive early and appropriate treatment to improve their survival.
Keywords: Meta-analysis; Pancreatic neoplasms; Survival; Young adult.
Copyright: © 2024 Renaldi K and William A.
Conflict of interest statement
No competing interests were disclosed.
Figures
Similar articles
-
Treatment patterns and survival in patients with early-onset pancreatic cancer.Cancer. 2021 Oct 1;127(19):3566-3578. doi: 10.1002/cncr.33664. Epub 2021 Jul 6. Cancer. 2021. PMID: 34228820 Free PMC article.
-
Demographic, clinical, and pathological features of early onset pancreatic cancer patients.BMC Gastroenterol. 2018 Sep 12;18(1):139. doi: 10.1186/s12876-018-0866-z. BMC Gastroenterol. 2018. PMID: 30208959 Free PMC article.
-
Clinical and genomic characterisation of early-onset pancreatic cancer.Eur J Cancer. 2023 Nov;194:113338. doi: 10.1016/j.ejca.2023.113338. Epub 2023 Sep 9. Eur J Cancer. 2023. PMID: 37793216
-
Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.J Hepatobiliary Pancreat Sci. 2023 Dec;30(12):1324-1333. doi: 10.1002/jhbp.1359. Epub 2023 Sep 26. J Hepatobiliary Pancreat Sci. 2023. PMID: 37750364 Review.
-
Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.Int J Surg. 2019 Nov;71:91-99. doi: 10.1016/j.ijsu.2019.09.014. Epub 2019 Sep 20. Int J Surg. 2019. PMID: 31546033
References
-
- Ferlay JEM, Lam F, Laversanne M, et al. : Global cancer observatory: Cancer today. 2024 [cited 2024 26 Feb]. Reference Source
-
- NIH national cancer institute SEER program: Cancer stat facts: Pancreatic cancer. 26 Feb 2024. Reference Source
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical